Conditional inactivation of CXCR2 in mice and generation of bone marrow chimeras

MS Maximilian J Schloss
MH Michael Horckmans
KN Katrin Nitz
JD Johan Duchene
MD Maik Drechsler
KB Kiril Bidzhekov
CS Christoph Scheiermann
CW Christian Weber
OS Oliver Soehnlein
SS Sabine Steffens
request Request a Protocol
ask Ask a question
Favorite

We induced homologous recombination in embryonic stem (ES) cells using a construct containing 4.9 kb of gDNA, including exon 1 and part of intron 1–2, an IRES‐LacZ cassette and Neo Cassette were inserted in between Frt sites, a loxP‐site was introduced in 5′ direction to the Neo cassette, and 2.9 kb of gDNA, including CXCR2 exons 2 and 3, was flanked by loxP sites (floxed). The construct was finished by introducing a 3.5‐kb fragment of gDNA serving as 3′ recombination arm (Appendix Fig S3). Correctly targeted ES cell clones were injected into blastocysts to produce a chimeric mouse that transmitted the modified allele through the germ line. A male heterozygous for the targeted allele was bred with a female expressing ubiquitous Flippase (Flp) transgene to ultimately produce animals that had deleted the IRES‐LacZ and Neo cassettes, preserving the loxP sites flanking exons 2 and 3. Those homozygous animals were bred with mice expressing a MRP8‐Cre transgene (Passegue et al, 2004) to ultimately produce animals that had deleted CXCR2 coding exons into neutrophils.

C57BL/6J wild‐type mice (Janvier) underwent lethally whole body irradiation (2 × 5 Gy). Donor bone marrow cells were obtained from Mrp8‐CreCXCR2flox or CXCR2flox mice (litermates). After flushing bones (femur, tibia, humerus), cells were washed, filtered, and intravenously injected (4 × 106 cells/mouse) in sterile saline into recipient mice 1 day after irradiation. Post‐transplantation, recipient mice were reconstituted for another 6 weeks before undergoing LAD occlusion surgical procedure.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A